Background. Consultation of a nephrologist is important in aligning care for patients with chronic kidney disease (CKD) at the primary-secondary care interface. However, current consultation methods come with practical difficulties that can lead to postponed consultation or patient referral instead. Objective. This study aimed to investigate whether a web-based consultation platform, telenephrology, led to a lower referral rate of indicated patients. Furthermore, we assessed consultation rate, quality of care, costs and general practitioner (GPs') experiences with telenephrology. Methods. Cluster randomized controlled trial with 47 general practices in the Netherlands was randomized to access to telenephrology or to enhanced usual care. A total of 3004 CKD patients aged 18 years or older who were under primary care were included (intervention group n = 1277, control group n = 1727) and 2693 completed the trial. All practices participated in a CKD management course and were given an overview of their CKD patients. Results. The referral rates amounted to 2.3% (n = 29) in the intervention group and 3.0% (n = 52) in the control group, which was a non-significant difference, OR 0.61; 95% CI 0.31 to 1.23. The intervention group's consultation rate was 6.3% (n = 81) against 5.0% (n = 87) (OR 2.00; 95% CI 0.75-5.33). We found no difference in quality of care or costs. The majority of GPs had a positive opinion about telenephrology. Conclusion. The data in our study do not allow for conclusions on the effect of telenephrology on the rate of patient referrals and provider-to-provider consultations, compared to conventional methods. It was positively evaluated by GPs and was non-inferior in terms of quality of care and costs.
Introduction
Care for patients with chronic kidney disease (CKD) poses a challenge for GPs due to the complexity of the disease and related comorbidity. Besides the risk of end-stage renal failure, CKD increases the risk of premature development of cardiovascular disease (1) . To attenuate these risks, structured care including alignment between primary and secondary care is necessary (2) . Management of CKD requires patient-centred care that should be provided in a primary care setting where possible and in a secondary care setting where necessary. In the UK, the National Institute for Health and Care Excellence (NICE) guidelines on CKD provide GPs with tools to decide which healthcare setting is best suited for providing patient's the required care (3) . In the Netherlands, the interdisciplinary CKD guideline for primary care and nephrology serves the same purpose (4) .
Within the Dutch healthcare system, consultation between GPs and specialists by phone is common practice and the existence of multiple interdisciplinary guidelines strengthens this approach. Consultation can be applied when the GP seeks expert knowledge or advice on for example an uncommon medical condition or test result, but also in situations where the patient's illness is too complex or serious to solely manage in primary care, but does not require referral to a specialist. The advice of a nephrologist by means of consultation may increase quality of care (QoC) in a primary care setting and could limit referrals to only those that need an in-person referral. However, the consultation process is not always straightforward and can lead to postponed consultation or patient referrals instead (5) .
Recently, in the Netherlands, the Radboud University Medical Center (RUMC) Departments of Primary and Community Care and of Nephrology devised a web-based consultation system: telenephrology. This system is an alternative to consultation by telephone or e-mail and has potential benefits: it is more time efficient, GPs and nephrologists can use it independently of each other at a time convenient to them, there is a digital report of the consultation and data is securely transferred (6, 7) . This approach shares many similarities with teledermatology, the first teleconsultation application to be widely embedded in Dutch general practice and an approach that decreased patient referrals and healthcare costs (8).
We assumed that when the consultation process is low barrier and the nephrologist's advice and knowledge become available to the GP, the need for in-person referral may be reduced. The primary aim was to investigate whether the use of telenephrology led to a lower in-person referral rate. Secondarily, we assessed the consultation rate between GPs and nephrologists, analyzed whether use of telenephrology was associated with higher QoC and performed a basic cost analysis. Tertiary aims were to report the number of newly diagnosed CKD patients during the trial, and their referral and consultation rates. Finally, we evaluated GPs' opinion on telenephrology.
Subjects and methods
The CONTACT study ('Consultation Of Nephrology by Telenephrology Allows optimal Chronic kidney disease Treatment in primary care') is a cluster randomized controlled trial (Netherlands Trial Registration code 2368).
Selection criteria
We recruited general practices during a CKD management course for GPs in the Netherlands. The practices did not have access to telenephrology before.
We defined the CKD population as all patients 18 years or older who met the CKD criteria [estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m 2 and/or albuminuria] based on data between 2008 and 2011 from the practices' electronic medical records (EMRs) (3, 9) . From there we included those patients who according to the Dutch interdisciplinary CKD guideline for primary care and nephrology would qualify for consultation or referral based on eGFR, albuminuria and age (4) .
The guideline criteria for recommended consultation were (a) patients aged ≥ 65 with an eGFR 30-45 ml/min/1.73 m 2 and no severe albuminuria and (b) patients aged < 65 with an eGFR 45-60 ml/min/1.73 m 2 and no severe albuminuria. The criteria for recommended referral were (a) patients aged ≥ 65 with an eGFR <30 ml/min/1.73 m 2 regardless of albuminuria status; (b) patients aged < 65 with an eGFR <45 ml/min/1.73 m 2 regardless of albuminuria status and (c) patients with severe albuminuria.
All participating practices were given overviews stating which of their patients met the consultation and referral criteria. Practices were free to follow up on these recommendations. The GPs reported which patients were already under secondary renal care. These patients were excluded from analysis. The intervention group had access to telenephrology between March 2011 and June 2012.
Consultation
In the intervention group, the GP could use the telenephrology application from the EMR. It functions as an add-on to the existing electronic referral system. Essential patient data on medical history, medication, laboratory results and blood pressure were automatically extracted. Telenephrology accessed individual patient data from the EMR only after the GP opened the consultation module for that specific patient. If the GP judged information from the medical history as not applicable, e.g. privacy-sensitive information, this could be removed. The nephrologist was notified about the consultation by e-mail or text message and consequently advised the GP on how to treat the patient in primary care, to refer directly, or to refer later if additional diagnostic information met conditions specified by the nephrologist. Subsequently, the GP was informed when a reply had arrived. Requested additional information could be given in a follow-up consultation. Moreover, the GP could ask for clarification or pose additional questions.
GPs in the control practices used conventional consultation methods. Consultations were not reimbursed for GPs.
Data security
The data connection between the EMR and the telenephrology application is similar to what is used for electronic referral or teledermatology. GPs log on to their EMR system with their credentials and have a direct single sign-on (SSO) which is secure sockets layer (SSL) encrypted to access telenephrology. The connection can only be activated by the GP from the EMR of a specific patient after informed consent by the patient. The data shared through telenephrology is SSL encrypted and only retrievable for the approached specialist who logs on using a two-factor authentication. The telenephrology service provider is certified to ISO 27001-2013 and NEN 7510 standards and complies with Dutch privacy legislation regarding patient data (Wet Bescherming Persoonsgegevens). The service provider employs a security officer and has a privacy officer on call.
Data sources
All referrals were reported by both the GPs and the nephrologists in an online survey system. Consultations in the control group were reported in a similar way. Telenephrology consultations were automatically logged by the facilitating company. Data for QoC and cost analysis were retrieved from the EMRs. A total of five different General Practice Information Systems were used across the practices to serve as EMR.
Outcomes
The primary outcome was the difference in referral rate between the telenephrology and control group, defined as the number of patients referred to secondary renal care as a fraction of total number of included patients.
Our secondary outcomes were the difference in consultation rates by telephone or telenephrology as a fraction of total number of included patients and QoC defined as adherence to the advised monitoring criteria from the Dutch interdisciplinary CKD guideline (Supplementary Table S1 ). Included process indicators were (i) disease progression (assessment of eGFR or serum creatinine, albuminuria, glucose and blood pressure) and (ii) metabolic parameters [assessment of haemoglobin, calcium, phosphate, parathyroid hormone (PTH), serum albumin and potassium]. As a measure of GPs' awareness of CKD, we evaluated compliance with coding renal impairment as a separate entity on the EMR episode list with International Classification of Primary Care (ICPC) code U99.1 in case of an eGFR <60 ml/min/1.73 m 2 . Furthermore, we analyzed achievement of blood pressure targets <140/90 and <130/80 mmHg, judged by the mean of the two latest measurements.
For the main related medical costs, we included the number of contacts between patient and primary care, the number of blood samples taken per patient, erythropoietin prescribed, referrals to secondary renal care and telenephrology and telephone consultations during the trial period.
Tertiary outcomes were to report the incidence of CKD during the trial (i.e. patients that did not meet the CKD criteria at T0, but did at T1), and their referral and consultation rates.
All general practices that participated in the intervention group were sent an online questionnaire about their experience with telenephrology. Included topics were content, feasibility and ease of use (Supplementary Table S2 ).
Sample size
Based on 50 pre-trial telenephrology consultations, we expected a 40% difference in referral rate (10) . We expected that per group practice the guideline would advice consultation in 94-140 patients and referral in 17-23 patients (11) . However, data on renal function or proteinuria is not known for every patient. English data showed that in the general population, a renal function was available in 27% of patients (12) .
Therefore, we assumed consultation or referral would occur in 36 patients per group practice. Based on other studies and considering the fact that some patients had been referred earlier, we expected seven referrals per control practice (referral rate 19.4%) and four referrals (referral rate 11.1%) per intervention practice (13) .
We assumed an intracluster correlation coefficient of 0.04. Based on a P-value of 0.05 and a power of 80%, at least 38 practices had to be included.
Randomization
Randomization took place in blocks of two practices and was stratified according to the number of CKD patients allocated to the consultation group per practice. Based on the baseline study results, we regarded practices with less than 14 patients in the consultation group as low volume and the others were considered high volume (14) . The randomization was performed by an independent statistician unaware of practice characteristics.
Analyses
We used descriptive statistics to assess patient baseline characteristics, referral and consultation rates, adherence to QoC indicators and results from the questionnaire. Because of the hierarchical structure of the data (patients nested within practices) the analyses were based on multilevel logistic regression models (PROC GLIMMIX in SAS). The type of General Practice Information System was considered a confounder for the outcomes referral/consultation rate and QoC, as these could be affected by the quality of data recording. We performed models with a random intercept keeping the independent variable (General Practice Information System) fixed for both outcomes. For QoC outcomes, we applied per protocol analysis and excluded the patients that were referred to secondary renal care during the study period as their monitoring was left at the discretion of the nephrologist and corrected for baseline QoC. The difference in mean costs per patient was analysed with a multilevel analysis with a cluster-corrected robustness test (details are provided in Supplementary Table S3 ). Descriptive analysis was conducted using SPSS version 20.0 (IBM PASW statistics 20), multilevel logistic regression analysis was conducted using SAS V9.2 and cost analysis was conducted using STATA 13.
Results
Forty-seven general practices signed up, with 23 intervention practices with 58 GPs and 24 control practices with 70 GPs after randomization.
The 47 practices served a population of 207 469 people, of whom 3004 patients fulfilled the inclusion criteria ( Figure 1 ). Baseline characteristics were comparable between patients in the intervention (n = 1277) and control group (n = 1727) ( Table 1) . Twenty-nine patients were referred in the intervention group against 52 in the control group (referral rates of 2.3% and 3.0%, respectively), resulting in an odds ratio (OR) of 0.61 (95% CI 0.31-1.23).
The difference in consultation rate was also non-significant, 6.3% (n = 81) in the intervention group against 5.0% (n = 87) in the control group (Tables 2 and 4 ). Regarding QoC there was no difference on any of the process or outcome variables (Tables 3  and 4 ). In comparison to the baseline results, registration of eGFR <60 ml/min/1.73 m 2 on the EMR episode list increased by an absolute 14.9% in the intervention group and by 16.4% in the control group. In total, 232 patients were lost to follow-up, mostly due to passing away and moving (Supplementary Table S4 ). The mean costs per patient during the trial in the intervention group were €453.86; 95% CI 392.98-514.74 against €433.74; 95% CI 387.64-479.84 in the control group (P = 0.60).
Patients newly diagnosed with CKD stage 3 or worse during the trial amounted 338/89 659 in the intervention group and 469/117 810 in the control group.
We received 38 completely filled out user evaluation questionnaires from 19/23 intervention practices. Twenty-seven GPs felt that the content of information sent via telenephrology was good. Ease of use was deemed good by 15 respondents, reasonable by 14 and insufficient by 3. Twenty-six GPs mentioned that telenephrology had added to their knowledge of kidney disease. Thirty respondents were pleased with the feasibility of telenephrology and twenty-nine would recommend telenephrology to colleagues. Six GPs did not make use of telenephrology.
Discussion

Summary
There was no difference in referral rates between the intervention and the control group (OR 0.61).
We also found no significant differences in consultation rate, QoC and costs. The majority of GPs had a positive opinion on telenephrology.
The referral rates of only 2.3% (n = 29) in the intervention group and 3.0% (n = 52) in the control group were much lower than our expected referral rates of 11.1% and 19.4%. This has resulted in a lower power of the study.
Strengths and limitations
A key strength of our trial is that we studied telenephrology in a routine general care setting without any further interventions during the trial, besides the overview of patients with CKD we provided. Offering both intervention and control practices, these overviews created the possibility to measure the effect of telenephrology and even out the effect of feedback arising from the overviews.
We provided a realistic view on the GPs' QoC by concentrating on patients who receive their CKD care in primary care, excluding those already under specialist care.
Several limitations should be considered. We applied the guideline classification based on single creatinine and albuminuria assessments whereas at least two and three measurements are advised. This might have led to less accurate classification. Also, there is a possibility of contamination bias as the control group received education and overviews of their CKD population as a result of our study design to accurately measure the effect of telenephrology.
QoC might be underestimated due to analysis of data routinely recorded in the EMR. For example, blood pressure was measured, The initial tertiary aim to analyze referrals and consultations in CKD patients newly diagnosed during the trial was not completed because the follow-up was too short and variable. Also, we could not conclude from the data whether erythropoietin prescriptions were initiated before or during the trial. Due to this limitation, erythropoietin was not included in the cost analysis.
Comparison with existing literature
In comparison with our results other studies on telenephrology or provider-to-provider electronic consultations also reported referral reductions in absolute numbers, but not on a statistical significant level. A study by Garcia Garcia et al. (15) showed a 15% reduction in referrals in patients with CKD stage 3 and hypertension, following a shared care model that also included monthly face-to-face consultations and education between GPs and nephrologists. A UK-based study reported a reduction in referrals from 30 to 8 patients after introduction of a CKD e-consultation service (16) . In Canada, Keely et al. implemented an e-consultation service for a wide range of subjects. They reported that in 43% of consultations a traditional referral was originally contemplated, but was now avoided. For consultations regarding nephrology (n = 16), just over 60% of referrals were avoided (17) . In the field of dermatology, a Dutch clinical trial about teledermatology did show a significant rate of prevented referrals in the total population of 68% after analysis of approximately 37 000 consultations (8). The high number of consultations led to adequate power in this trial.
In general, it appears difficult to substantiate the benefits of e-health with high levels of evidence. A systematic review of 27 studies on provider-to-provider e-consultations showed good feasibility and high GP satisfaction, but researchers did mention that effects on referrals, costs and clinical outcomes remained unclear (18) . Our study showed similar results compared with the systematic review. However, despite difficulties to demonstrate direct benefits of telenephrology, outcomes of semi-structured interviews with GPs, nephrologists and patients with CKD 3-4 showed that patients and doctors preferred CKD management in a primary care setting wherein the GP had access to a nephrologist. Both GPs and nephrologists strongly supported the use of electronic consultation systems (19) .
Implications for research and/or practice
We found a non-significant reduction in referral rate with an odds ratio of 0.61. The biggest difference in referral rate was to be expected in the consultation group, where hypothetically telenephrology-facilitated consultation would empower GPs to provide care for more complex patients with CKD. In this group, there was a 40% relative difference in referral rate. However, the observed referral rate was far lower than we had estimated in our sample size calculation (3% against an expected 19.4%) and limits the possibilities to draw firm conclusions. With regard to the large difference between the expected and actual referral rate, it would be valuable to further explore the GPs' considerations when it comes to referral and consultation. The total number of consultations was too small to conclude that telenephrology is a more stimulating tool to facilitate interdoctor consultations compared to conventional consultations methods.
There was no difference in QoC between the GPs in the intervention and control groups (Supplementary Table S5 ). Another possible explanation for lack of a difference could be contamination bias. Arguably, because of the study design, the control group partly acted as if they were an intervention group due to their participation in the CKD management course, their intrinsic motivation to participate in the study, the provision of the overview of CKD patients and their active registration of consultations and referrals (20) .
Conclusion
The data in our study do not allow for conclusions on the effect of telenephrology on the rate of patient referrals and provider-toprovider consultations, compared to conventional methods. It was positively evaluated by GPs and was non-inferior in terms of quality of care and costs. In our opinion, telenephrology deserves further evaluation before definite recommendations can be made.
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